Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
CST3 Gene Cerebral amyloid angiopathy NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 23 | 30 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics, part of Exact Sciences United States | 346 | 160 |
|
Invitae Hereditary Cerebral Small Vessel Disease Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 24 | 10 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Hereditary Lymphoid/Immunodeficiency Predisposition Panel Genetic Services Laboratory University of Chicago United States | 27 | 66 |
|
Neurodegenerative panel _v.2.0 CGC Genetics Unilabs Portugal | 15 | 207 |
|
Hereditary amyloidosis (WES based NGS panel of 21 genes, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 21 |
|
Cerebral small vessel disease panel CGC Genetics Unilabs Portugal | 1 | 18 |
|
CGC Genetics Unilabs Portugal | 1 | 20 |
|
Cerebral amyloid angiopathy (sequence analysis of CST3 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 49 |
|
DEMENTIA AND ALZHEIMER EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 68 |
|
ALZHEIMER AND DEMENTIA EXOME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 68 |
|
HEREDITARY AMYLOIDOSIS SYNDROME PANEL Laboratorio de Genetica Clinica SL Spain | 1 | 22 |
|
Genologica Medica Spain | 44 | 19 |
|
Cerebral amyloid angiopathy: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 3 | 3 |
|
Cerebral amyloid angiopathy, CST3-Related Laboratory for Molecular Diagnostics Center for Nephrology and Metabolic Disorders Germany | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.